MEDICIANZ ALFENTANIL, MEDSURGE ALFENTANIL (Medicianz Healthcare Pty Ltd)
Product name
MEDICIANZ ALFENTANIL, MEDSURGE ALFENTANIL
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
157 working days (255)
Active ingredients
alfentanil hydrochloride
Registration type
New generic medicine
Indication
MEDICIANZ ALFENTANIL, MEDSURGE ALFENTANIL (solution for injection) are indicated for intravenous use by specialist anaesthetists and their trainees as:
- an analgesic supplement given by incremental intravenous boluses or continuous infusion; and
- an anaesthetic induction agent where in patients undergoing in-patient surgery, when endotracheal intubation and controlled ventilation are to be used.
Because of its rapid onset and short duration of action, intravenous alfentanil (as hydrochloride) is particularly suited as a narcotic analgesic for short procedures and outpatients, provided that the patients are maintained under appropriate post-operative surveillance. However, intravenous alfentanil (as hydrochloride) is also useful as an analgesic supplement for procedures of medium to long duration, since periods of very painful stimuli can be easily overcome by administration of small increments of alfentanil (as hydrochloride) or by adapting the infusion rate.